Mighty Therapeutics Holdings Inc - Company Profile
Powered by 
All the sales intelligence you need on Mighty Therapeutics Holdings Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Mighty Therapeutics Holdings Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Mighty Therapeutics Holdings Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Mighty Therapeutics Holdings Inc (Mighty Therapeutics) is a clinical-stage biopharmaceutical company that focuses on the discovery, advancement, and marketing of novel therapies for diseases associated with mitochondrial dysfunction and old age-related diseases. Its therapeutic area of interest includes rare genetic disorders involving mitochondrial dysfunction, neurodegenerative disorders, and ophthalmic disorders.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Mighty Therapeutics is focused on developing therapies for diseases involving mitochondrial dysfunction. The company is in the last stage of clinical studies in ophthalmic diseases involving the usage of elamipretide, entailing dry AMD, rare neuromuscular disorders, such as primary mitochondrial myopathy and Duchenne muscular dystrophy, and rare cardiomyopathies, such as Barth syndrome. It is also evaluating SBT-272, which is in the second-generation clinical stage, for rare neurological disease indications, including amyotrophic lateral sclerosis. Other products that are in the discovery stage of clinical trials are the SBT-255, focusing on cardiology and muscle myopathy, and the SBT-589 for neurological disorders.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer